Second line treatment of acromegaly: Pasireotide or Pegvisomant?
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference81 articles.
1. Acromegaly;Melmed,2010
2. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly;Holdaway;Eur J Endocrinol,2008
3. The future of somatostatin receptor ligands in acromegaly;Gadelha;J Clin Endocrinol Metab,2022
4. Acromegaly: assessing the disorder and navigating therapeutic options for treatment;Melmed;Endocr Pract,2014
5. The participants of the German Acromegaly Register. Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey;Schöfl;Eur J Endocrinol,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Pegvisomant in the Treatment of Acromegaly;Archives of Medical Research;2023-12
2. The Multibiomarker Acro-TIME Score Predicts fg-SRLs Response: Preliminary Results of a Retrospective Acromegaly Cohort;The Journal of Clinical Endocrinology & Metabolism;2023-11-17
3. Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly;The Journal of Clinical Endocrinology & Metabolism;2023-08-22
4. Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas;International Journal of Molecular Sciences;2023-06-08
5. Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors;Frontiers in Endocrinology;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3